In 2023, Bayer advanced its pipeline with eight investigational new drug (IND) applications. Four assets are expected to advance to phase II by the end of 2024. High Yield Savings Offers .

Bayer Leverkusen are in advanced talks to sign Liverpool defender Jarell Quansah with an agreement close; Leverkusen ...

Bayer (OTCPK:BAYZF) (OTCPK:BAYRY) said on Wednesday that the U.S. FDA has approved its blockbuster oral hormone blocker, darolutamide, in combination therapy, to treat metastatic hormone-sensitive ...

Bayer has advanced its small-molecule drug BAY 2927088 into phase 3 for non-small cell lung cancer (NSCLC) with HER2 activating mutations, ...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today initiation of a Phase I clinical trial with 225 Ac-GPC3 (BAY 3547926), an investigational targeted alpha radiopharmaceutical being developed ...

Bayer HealthCare has introduced Bayer Advanced aspirin, which can relieve pain twice as fast as previous Bayer aspirin tablets, according to the company. Practice Specialties ...

Jonathan Tah is in advanced talks to join Bayern Munich as a free agent after his Bayer Leverkusen contract expires this summer. The 29-year-old defender confirmed in April that he would leave ...